אינג'י 10 מג80 מג טבליות

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

EZETIMIBE; SIMVASTATIN

थमां उपलब्ध:

MERCK SHARP & DOHME ISRAEL LTD

ए.टी.सी कोड:

C10AA01

फार्मास्यूटिकल फॉर्म:

טבליה

रचना:

EZETIMIBE 10 MG; SIMVASTATIN 80 MG

प्रशासन का मार्ग:

פומי

प्रिस्क्रिप्शन प्रकार:

מרשם נדרש

द्वारा बनाया गया:

MERCK SHARP & DOHME (ITALIA) S.P.A.

चिकित्सीय समूह:

SIMVASTATIN

चिकित्सीय क्षेत्र:

SIMVASTATIN

चिकित्सीय संकेत:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

प्राधिकरण की तारीख:

2012-04-30